Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
REXTA
BRANDED
Oxaliplatin 50 mg, Mechanism of action: both inter and intrastrand Pt-DNA crosslinks are formed.
Available at :
Share this article
Related
Articles
Zerpidio Officially Launched in Thailand: A New Breakthrough in Lung Cancer Therapy
by Admin Kalbemed | 04 Aug 2025
High-Protein, Omega-3 Oral Nutritional Supplements May Improve Cancer-Related Fatigue
by dr. Dedyanto Henky Saputra, M.Gizi | 31 Jul 2025
Serplulimab Approved for First-line Treatment of Extensive Stage Small Cell Lung Cancer (ES-SCLC) in the European Union
by dr. Dita Arccinirmala | 06 Feb 2025
Combination of Calcitriol with Calcium and Vitamin D Effectively Increases Bone Density in Patients with Type 2 DM and Osteoporosis
by dr. Esther Kristiningrum | 26 Mar 2024
Kalbe Supports Cancer Treatment in Indonesia Through the Construction of a Radiopharmaceutical Production Facility in the Country
by dr. Dita Arccinirmala | 22 Feb 2024
Get to Know Sarcoma, Rare Cancer of Bone and Soft Tissue
by dr. Vivian Keung | 21 Feb 2024
Oral Nutrition Suplemment Improves Iron Metabolism in Lung Cancer Patients
by dr. Dedyanto Henky Saputra, M. Gizi | 31 Jan 2024
Low Vitamin D Levels Increase the Risk of Paclitaxel-Induced Peripheral Neuropathy
by dr. Esther Kristiningrum | 23 Nov 2023
Single-Dose or Two-Dose Palonosetron in Pediatric Patients with Multiple-Day Chemotherapy
by dr. Hastarita Lawrenti | 26 Oct 2023
Recurrent Bone Fracture Prevention
by dr. Vivian Keung | 17 Oct 2023
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE